Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Vaccination and Autoimmune Inflammatory Rheumatic Diseases"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 30 June 2023 | Viewed by 696
Special Issue Editor
E-Mail Website1 Website2
Interests: vaccination (effectiveness, epidemiology); autoimmune inflammatory rheumatic diseases; immunosuppressive therapy; SARS-CoV-2; ANCA-associated vasculitis
Special Issue Information
The vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRDs) remains challenging. Despite the often substantially increased risk for infections, the reported vaccination rates for important vaccines (e.g., influenza) are low. In this context, concerns about the triggering of flare-ups of known AIIRDs or the induction of autoimmunity itself are prominent. Furthermore, vaccination effectiveness seems to be impaired because of immunosuppressive or immunomodulatory therapy.
This Special Issue addresses all aspects of vaccination related to autoimmune inflammatory rheumatic diseases. Topics include, but are not limited to, reports on vaccination efficacy under immunosuppressive therapy, autoimmune-related side effects and AIIRD flare-up induction due to vaccination, studies investigating the reasons for vaccination hesitancy or manuscripts on patient education regarding vaccination in immunocompromised patients with autoimmune inflammatory rheumatic diseases.
All kinds of papers, including original articles, reviews, meta-analyses and theoretical contributions are welcomed.
Dr. Marco L. Krasselt
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- autoimmune inflammatory rheumatic diseases
- vaccination rates
- vaccination efficacy
- vaccination hesitancy
- varicella zoster virus
- flare induction
- triggering of autoimmunity